X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Martin Shkreli, center, former hedge fund manager, arrives at federal court in Brooklyn in 2017. Photo: Peter Foley/Bloomberg Martin Shkreli, center, former hedge fund manager, arrives at federal court in Brooklyn in 2017. Photo: Peter Foley/Bloomberg

The Federal Trade Commission and New York Attorney General Letitia James on Monday sued disgraced pharmaceutical executive Martin Shkreli and his former company for “illegally monopolizing” the market for a drug used to treat potentially fatal parasitic infections.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Tom McParland

Tom McParland of New York Law Journal can be contacted at tmcparland@alm.com. Follow him on Twitter @TMcParlandALM.

More from this author

 

Corporate Governance: Avoiding and Responding to MisconductBook

For anyone who has been dealing with both the intended and unintended consequences of Dodd-Frank, Sarbanes-Oxley and other new laws and regulations, Corporate Go...

Get More Information
 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.